X @Bloomberg
Bloomberg·2026-01-28 17:44
Veradermics, a biopharmaceutical firm focused on hair restoration, is seeking to raise as much as $213.6 million in an IPO to help commercialize its hair re-growth pill. https://t.co/ifvYiq88P7 ...
Veradermics, a biopharmaceutical firm focused on hair restoration, is seeking to raise as much as $213.6 million in an IPO to help commercialize its hair re-growth pill. https://t.co/ifvYiq88P7 ...